首页> 外文会议>International Conference on Biomedical Engineering >Development, Optimization and Characterization of Nanoparticle Drug Delivery System of Cisplatin
【24h】

Development, Optimization and Characterization of Nanoparticle Drug Delivery System of Cisplatin

机译:顺铂纳米粒子药物递送系统的开发,优化与表征

获取原文

摘要

Purpose: Polymeric nanoparticles are frequently employed for drug delivery systems to perform a sustained release behavior of incorporated drug. These polymeric nanoparticles can be used for site specific targeting of encapsulated drug. The objective of present study was to develop a poly (lactide-co-glycolide) (PLGA) nanoparticles drug delivery system of anticancer drug cisplatin with higher therapeutic efficacy, lesser side effects, and with further development to advances in targeted chemotherapy. PLGA nanoparticles were prepared by double emulsion solvent evaporation method and characterized by their morphology, size, polydispersity index, zeta potential, drug encapsulation efficiency and in-vitro drug release in phosphate buffer saline (pH 7.4). The influences of several process parameters on the nanoparticles were observed. The results obtained from studies showed that nanoparticles developed in this study could be the nanoparticles for application in the controlled delivery of cisplatin for cancer therapeutics and may be considered promising in targeted therapy of cancer.
机译:目的:聚合物纳米颗粒通常用于药物递送系统,以进行掺入药物的持续释放行为。这些聚合物纳米颗粒可用于现场特异性靶向包封的药物。本研究的目的是开发聚(丙交酯 - 共乙酰胺)(PLGA)纳米颗粒的抗癌药物顺铂的药物递送系统,具有较高的治疗效果,较小的副作用,以及进一步发展以进一步发展靶向化疗。通过双乳液溶剂蒸发方法制备PLGA纳米粒子,其特征在于它们的形态,大小,多分散性指数,Zeta电位,药物包封效率和磷酸盐缓冲盐水(pH7.4)中的体外药物释放。观察到几种工艺参数对纳米颗粒的影响。从研究中获得的结果表明,该研究中开发的纳米颗粒可以是用于癌症治疗剂的顺铂的受控递送的纳米颗粒,并且可以被认为是癌症的有针对性的治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号